• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Camilla Heiberg Freiberg, Denmark

    Camilla Heiberg Freiberg, Denmark

  • Glen Elison, USA

    Glen Elison, USA

  • Len Johnrose, England

    Len Johnrose, England

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • Tso-Ta Huang, Taiwan

    Tso-Ta Huang, Taiwan

  • Mark Miller, UK

    Mark Miller, UK

  • Lombana, Spain

    Lombana, Spain

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • Ching-Liang Chu, Taiwan

    Ching-Liang Chu, Taiwan

  • Feng Gin Sun, China

    Feng Gin Sun, China

  • Dr. Janmejay Pradhan, India

    Dr. Janmejay Pradhan, India

  • Philip Brindle, England

    Philip Brindle, England

  • Purningam Jacob, India

    Purningam Jacob, India

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • Roy Taylor, Ireland

    Roy Taylor, Ireland
    roy

  • Yolanda Armendariz, Mexico

    Yolanda Armendariz, Mexico

  • João Marcos Andrietta, Brazil

    João Marcos Andrietta, Brazil

  • Bob Simonds, USA

    Bob Simonds, USA

  • Calum Ferguson, Scotland

    Calum Ferguson, Scotland

  • Art Eggert, USA

    Art Eggert, USA

  • Eddy Lefrancois, Canada

    Eddy Lefrancois, Canada

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Hiroshi Matsuyama, Japan

    Hiroshi Matsuyama, Japan

  • Semra Gokalp, Turkey

    Semra Gokalp, Turkey

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Angelique van der Lit-van Veldhuizen, Netherlands

    Angelique van der Lit-van Veldhuizen, Netherlands

  • Murat Morali, Turkey

    Murat Morali, Turkey

  • Steve

    Steve

  • Mauricio Dorin, Argentina

    Mauricio Dorin, Argentina

  • Carlos Gomez Matallanas, Spain

    Carlos Gomez Matallanas, Spain

  • Nicholas (Nic) Bowman, South Africa

    Nicholas (Nic) Bowman, South Africa

  • Fernando Ocampo Cardona, Colombia

    Fernando Ocampo Cardona, Colombia

  • Dr. Shelly Hoover, USA

    Dr. Shelly Hoover, USA

  • Claudia Cominetti, Italy

    Claudia Cominetti, Italy

  • Jean Waters, UK

    Jean Waters, UK

  • Jorge Melo, Brazil

    Jorge Melo, Brazil

  • Liam Dwyer, England

    Liam Dwyer, England

  • Danny Reviers, Belgium

    Danny Reviers, Belgium

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • JP

    JP

  • Zelina Brito, Brazil

    Zelina Brito, Brazil

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Malu Araujo Ribeiro, Brazil

    Malu Araujo Ribeiro, Brazil

  • Richard Clark, New Zealand

    Richard Clark, New Zealand

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Yannick Richard, Canada

    Yannick Richard, Canada
    yannickrichard

  • Xian-Zhang Niu, China

    Xian-Zhang Niu, China

  • Susan Anderson, USA

    Susan Anderson, USA

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login